KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Accounts Payables (2016 - 2025)

Astrana Health's Accounts Payables history spans 14 years, with the latest figure at $106.1 million for Q4 2024.

  • For Q4 2024, Accounts Payables rose 1069.61% year-over-year to $106.1 million; the TTM value through Dec 2024 reached $106.1 million, up 1069.61%, while the annual FY2024 figure was $106.1 million, 1069.61% up from the prior year.
  • Accounts Payables for Q4 2024 was $106.1 million at Astrana Health, up from $94.8 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $146.5 million in Q1 2024 and bottomed at $7.7 million in Q1 2020.
  • The 5-year median for Accounts Payables is $37.2 million (2020), against an average of $41.6 million.
  • The largest annual shift saw Accounts Payables tumbled 81.69% in 2023 before it surged 1069.61% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $36.1 million in 2020, then increased by 21.6% to $44.0 million in 2021, then increased by 12.77% to $49.6 million in 2022, then crashed by 81.69% to $9.1 million in 2023, then soared by 1069.61% to $106.1 million in 2024.
  • Per Business Quant, the three most recent readings for ASTH's Accounts Payables are $106.1 million (Q4 2024), $94.8 million (Q3 2024), and $38.2 million (Q2 2024).